Inclusion criteria in BE studies [Design Issues]

posted by BEQool  – Slovenia, 2023-05-05 12:42 (213 d 21:45 ago) – Posting: # 23543
Views: 963

(edited by on 2023-05-05 12:52)

❝ Just wish to mention that Gender is a between-subject factor (at least for most practical purposes ex-Thailand), so there is no particular gain in including Gender as a factor when you have Subject in the model unless there is a specific regulatory requirement.

maybe a stupid question but is Gender*Treatment also a between-subject factor (like Sequence and Gender here)?
In the article Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets by González-Rojano et al. it doesnt say anything about which factor they used (within- or between-subject) to test Gender*Treatment interaction.

Additionally, how do you know which factor is a within-subject and which is a between-subject? If anyone has an explanation in simple words :-)

Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,639 registered users;
39 visitors (0 registered, 39 guests [including 7 identified bots]).
Forum time: 09:28 CET (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz